Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.
作者： Daniel J Smyth , Duncan Webster , Lisa Barrett , Mark MacMillan , Lisa McKnight
DOI: 10.1155/2014/109046
关键词: Mass screening 、 Intensive care medicine 、 Health care 、 Guideline 、 Medicine 、 Health policy 、 Cohort study 、 Liver transplantation 、 Physical therapy 、 Hepatocellular carcinoma 、 Indirect costs
摘要: Chronic hepatitis C virus (HCV) infection increases all-cause mortality, rates of cirrhosis, hepatocellular carcinoma, liver transplantation and overall health care utilization. Morbidity mortality disproportionately affect individuals born between 1945 1975. The recent development well-tolerated highly effective therapies for chronic HCV represents a unique opportunity to dramatically reduce HCV-related complications their costs. Critical the introduction such will be well-designed provincial programming ensure immediate treatment access at highest risk complication, well-defined strategies address global needs traditionally high-risk marginalized populations. practitioners in New Brunswick created strategy that stratifies according those need, measures clinical impact, creates evaluation demonstrate significant direct indirect cost savings anticipated with curative treatments.
hindawi.com
core.ac.uk参考文章(35)
Guy W. Neff, Christopher W. Duncan, Eugene R. Schiff, The current economic burden of cirrhosis. Gastroenterología y Hepatología. ,vol. 7, pp. 661- 671 ,(2011)
Naomi Adelson, The embodiment of inequity: health disparities in aboriginal Canada. Canadian Journal of Public Health-revue Canadienne De Sante Publique. ,vol. 96, ,(2005) , 10.1007/BF03403702
J. M. Calvo Romero, J. M. Puerto Pica, Gastric adenocarcinoma and kidney transplantation Gastroenterología y Hepatología. ,vol. 21, pp. 260- ,(1998)
Bryce D Smith, Rebecca L Morgan, Geoff A Beckett, Yngve Falck-Ytter, Deborah Holtzman, Chong-Gee Teo, Amy Jewett, Brittney Baack, David B Rein, Nita Patel, Miriam Alter, Anthony Yartel, John W Ward, Centers for Disease Control and Prevention, None, Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. ,vol. 61, pp. 1- 32 ,(2012)
Swarna Weerasinghe, Peter Stevens, Duncan Webster, Morbidity and mortality rates in a NOVA SCOTIA First Nations Community, 1996-1999. Canadian Journal of Public Health-revue Canadienne De Sante Publique. ,vol. 95, pp. 369- 374 ,(2004) , 10.17269/CJPH.95.538
G Dusheiko, Side effects of alpha interferon in chronic hepatitis C. Hepatology. ,vol. 26, ,(1997) , 10.1002/HEP.510260720
Lisa I. Backus, Derek B. Boothroyd, Barbara R. Phillips, Pamela Belperio, James Halloran, Larry A. Mole, A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C Clinical Gastroenterology and Hepatology. ,vol. 9, pp. 509- 516 ,(2011) , 10.1016/J.CGH.2011.03.004
Kathleen A. Brady, Mark Weiner, Barbara J. Turner, Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals Journal of Infection. ,vol. 59, pp. 62- 69 ,(2009) , 10.1016/J.JINF.2009.04.008
Jacqueline G. O'Leary, Rita Lepe, Gary L. Davis, Indications for liver transplantation Gastroenterology. ,vol. 134, pp. 1764- 1776 ,(2008) , 10.1053/J.GASTRO.2008.02.028
Piero L. Almasio, Sergio Babudieri, Giorgio Barbarini, Maurizia Brunetto, Dario Conte, Pietro Dentico, Giovanni B. Gaeta, Claudio Leonardi, Massimo Levrero, Francesco Mazzotta, Aldo Morrone, Lorenzo Nosotti, Daniele Prati, Maria Rapicetta, Evangelista Sagnelli, Gaetano Scotto, Giulio Starnini, Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) Digestive and Liver Disease. ,vol. 43, pp. 589- 595 ,(2011) , 10.1016/J.DLD.2010.12.004